NCT05974254

Brief Summary

This randomized controlled trial will test the hypothesis that patients receiving an intraoperative auricular acupuncture protocol will require less postoperative opioid analgesic use compared to those who do not receive acupuncture in the setting of a multimodal analgesic protocol for patients receiving surgery to repair distal radius fractures at a Level 1 trauma center under brachial plexus anesthesia with sedation.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 3, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

October 9, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

March 3, 2026

Status Verified

December 1, 2025

Enrollment Period

2.1 years

First QC Date

July 26, 2023

Last Update Submit

March 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total opioid analgesic use for 14 days after surgery

    Total opioid given in hospital and taken at home, converted to oral morphine equivalents

    14 days

Secondary Outcomes (2)

  • Pain scores

    14 days

  • Incidence of side effects associated with opioid use

    14 days

Study Arms (2)

Electroauricular acupuncture

EXPERIMENTAL

Immediately after Level 2 sedation is achieved, an enhanced auricular trauma protocol (ATP) will be administered on the ear ipsilateral to the operative side at 8 ear points (Hypothalamus, Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Shen Men, Insula, Vagus) as described by Cheng (2022). The original ATP was described by Helms (2011). Seirin L 0.2 x 30 mm needles will be placed at Hypothalamus and Shen Men points. Seirin J 0.18 x 15 mm needles will be placed at Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Vagus, and Insula points. Electrostimulation using an ITO ES 130 microstimulator at 30 HZ with Level 4 intensity, will be applied with the positive lead (red) on Hypothalamus and negative lead (black) at Shen Men for 60 minutes. All needles will be removed 1 hour after insertion.

Device: Acupuncture

No acupuncture

NO INTERVENTION

No acupuncture treatment given

Interventions

Electroacupuncture

Electroauricular acupuncture

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient ages 18-64
  • American Society of Anesthesiologists Physical Status 1, 2, or 3
  • Patients scheduled to undergo distal radius ORIF under brachial plexus nerve block

You may not qualify if:

  • Renal dysfunction (Serum Cr \> 1.2) - excluded due to potential for altered metabolism of anesthetic and perioperative medications
  • Allergy to any of the standard anesthetic agents
  • Patient inability to properly communicate with investigators
  • Patient or surgeon refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ben Taub Hospital

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Wrist FracturesPain, Postoperative

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, BonePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Jaime Ortiz, MD, MBA

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The patients will be under sedation in the operating room and will not be aware of which treatment group they are in. The PACU team and outcomes assessor will not be aware of patient group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial Group 1 - acupuncture treatment Group 2 - no acupuncture treatment 70 patients per group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology

Study Record Dates

First Submitted

July 26, 2023

First Posted

August 3, 2023

Study Start

October 9, 2023

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

March 3, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations